Immunologic tests of value in diagnosis

References

• Zacharski LR, Kyle RA. Significance of extreme elevation of erythrocyte sedimentation rate. JAMA 1967: 202: 264–6
   PubMed Web of Science ®Google Scholar
• Payne RW. Causes of grossly elevated erythrocyte sedimentation rate. Practitioner 1968: 200: 415–7
   PubMedGoogle Scholar
• Hart GD, Soots M, Sullivan J, et al. Significance of extreme elevation of erythrocyte sedimentation rate. Appl Ther 1970: 12: 12–3
   Google Scholar
• Abengowe CU. Clinical importance of grossly increased erythrocyte sedimentation rate. (Letter) Can Med Assoc J 1975: 113: 929–30
   PubMed Web of Science ®Google Scholar
• Honig S, Gorevic P, Wetosmann G. et al. C-reactive protein in systemic lupus erythematosus patients. Arthritis Rheum 1977: 20: 65–70
   PubMedGoogle Scholar
• Kunkel HG, Muller-Eberhard HJ, Fudenberg HH, et al. Gamma globulin complexes in rheumatoid arthritis and certain other conditions. J Clin Invest 1961: 40: 117–29
   PubMed Web of Science ®Google Scholar
• Torrigiani G, Roitt IM. Anti-globulin factors in sera from patients with rheumatoid arthritis and normal subjects. Ann Rheum Dis 1967: 26: 334–40
   PubMed Web of Science ®Google Scholar
• Chodirker WB, Tomssi TB Jr. Low-molecular-weight rheumatoid factor. J Clin Invest 1963: 42: 876–84
   PubMed Web of Science ®Google Scholar
• Schrohenloher RE. Characterization of the gamma-globulin complexes present in certain sera having high titers of anti-gamma-globulin activity. J Clin Invest 1966: 45: 501–12
   PubMed Web of Science ®Google Scholar
• Heimer R, Levin FM. Gamma-1A and gamma-2 rheumatoid factors. Arthritis Rheum 1964: 7: 738
   Google Scholar
• Adachi M, Atsumi T, Saito N. Detection of 1gA- and 1gG-rheumatoid factors by antiglobulin augmentation technique. Int Arch Allergy Appl Immunol 1969: 35: 77–87
   PubMedGoogle Scholar
• Singer JM, Plotz CM. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Am J Med 1956: 21: 888–92
   PubMed Web of Science ®Google Scholar
• Waaler E. On the occurrence of a factor in human serum activating the specific agglutination of sheep red corpuscles. Acta Pat hoi Microbiol Scand 1940: 17: 172–88
   Google Scholar
• Rose HM, Ragan C, Pearce E, et al. Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Prog Soc Exp Biol Med 1948: 68: 1
   PubMed Web of Science ®Google Scholar
• Hollander JL, McCarty DJ Jr. Arthritis and allied conditions: a textbook of rheumatology. 8th ed. Philadelphia: Lea& Feblger, 1972: 153–71
   Google Scholar
• Wager O. Some hemagglutination tests with sera of patients suffering from rheumatoid arthritis. Ann Med Exp Biol Fenn 1950: 28: 37–44
   Google Scholar
• Ansell BM, Holborow J, Zutshi D, et al. Comparison of three serological tests in adult rheumatoid arthritis and Stili's disease (juvenile rheumatoid arthritis). Ann NY Acad Sci 1969: 168: 21–9
   PubMed Web of Science ®Google Scholar
• Waller MV, Decker B, Toone EC Jr. et al. Evaluation of rheumatoid factor tests. Arthritis Rheum 1961: 4: 579–91
   PubMedGoogle Scholar
• Bartfeld H. Distribution of rheumatoid factor activity in nonrheumatoid states. Ann NY Acad Sci 1969: 168: 30–40
   PubMed Web of Science ®Google Scholar
• Abruzzo JL, Heimer R. 1gG anti-1gG antibodies in rheumatoid arthritis and certain other conditions. Ann Rheum Dis 1974: 33: 256–61
   Google Scholar
• Torrigianl G. Roitt IM. Lloyd KN, et al. Elevated 1gG antiglobulins in patients with sero-negative rheumatoid arthritis. Lancet 1970: 1: 14–6
   PubMed Web of Science ®Google Scholar
• Panush RS, Bianco NE, Schur PH, et al. Serum and synovial fluid 1gG. 1gA and 1gM antigamma-globulins in rheumatoid arthritis. Arthritis Rheum 1971: 14; 737–47
   PubMedGoogle Scholar
• Tapanea RJ, Rawson AJ, Hollander JL. Serum anti-immunoglobulins in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 1972: 15: 153–6
   PubMedGoogle Scholar
• Sharp JT, Calkins E, Cohen AS, et al. Observations on the clinical, chemical and serological manifestations of rheumatoid arthritis, based on the course of 154 cases. Medicine 1964: 43: 41–58
   PubMed Web of Science ®Google Scholar
• Shievers K. The rheumatoid factor in definite rheumatoid arthritis. Acta Rheum (Suppl) 1965: 9: 1
   Google Scholar
• Bland JH, Brown EW. Seronegative and seropositive rheumatoid arthritis; clinical, radiological, and biochemical differences. Ann Intern Med 1964: 60: 88–94
   PubMed Web of Science ®Google Scholar
• Mongan ES, Cass RM, Jacox RP, et al. A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis. Am J Med 1969: 47: 23–35
   PubMed Web of Science ®Google Scholar
• Ruddy S, Britton MC. Schur PH. Complement components in synovial fluid: activation and fixation in seropositive rheumatoid arthritis. Ann NY Acad Sci 1969: 168: 161–72
   PubMed Web of Science ®Google Scholar
• Winchester RJ, Agnello V, Kunkel HG, et al. Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis: partial characterization and relationship to lowered complement levels. Clin Exp Immunol 1970: 6: 689–706
   PubMed Web of Science ®Google Scholar
• Laurence JS. Current comments; epidemiology of rheumatoid arthrttis. Arthritis Rheum 1963: 6: 166–71
   Google Scholar
• Cathcart ES, O'Sullivan JB. A longitudinal study of rheumatoid factors in a New England town. Ann NY Acad Sci 1969: 168: 41–51
   PubMed Web of Science ®Google Scholar
• Ziff M. Possible clinical and pathologic associations of rheumatoid factor. Arthritis Rheum (Suppl) 1963: 6: 481–9
   PubMedGoogle Scholar
• Peltier AP et al. Pathobiology annual. New York; Appleton-Century-Crofts. 1972
   Google Scholar
• Sharp GC, Irvin WS, May CM, et al. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systemic lupus erythematosus and other rheumatic diseases. N Engl J Med 1976: 295: 1149–54
   PubMed Web of Science ®Google Scholar
• Block KJ, Buchanan WW, Wohl MJ, et al. Sjögren's syndrome: a clinical, pathological and serological study of 52 cases. Medicine 1965: 44: 187–231
   PubMed Web of Science ®Google Scholar
• Quismorio RP. Immunologic phenomena in patients with systemic lupus erythematosus. In: Dubois EL. ed. Lupus erythematosus? a review of the current status of discoid and systemic lupus erythematosus and their variants. 2nd ed. Los Angeles; University of Southern California Press. 1974
   Google Scholar
• Burnham TK, Fine G, Neblett TR. The immunofluorescent tumor imprint technique. II. The frequency of antinuclear factors in connective tissue diseases and dermatoses. Ann Intern Med 1966: 65: 9–19
   PubMed Web of Science ®Google Scholar
• Rodnan GP, ed. Primer on the rheumatic diseases. JAMA 1973: 224 Suppl: 661–812
   Google Scholar
• Hollander JL, McCarty DJ Jr. Arthritis and allied conditions: a textbook of rheumatology. 8th ed. Philadelphia; Lea& Febiger. 1972
   Google Scholar
• Notman DD, Kurata N, Tan EM. Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med 1975: 83: 464–9
   PubMed Web of Science ®Google Scholar
• Ritchie RF. Antinucleolar antibodies: their frequency and diagnostic association. N Engl J Med 1970: 282: 1174–8
   PubMed Web of Science ®Google Scholar
• Fudenberg HH, Stites DP, Caldwell JL, et al, eds. Basic and clinical Immunology. 2nd ed. Los Altos. Calif: Lange Medical Publications, 1978
   Google Scholar
• Reichlln M, Mattioli M. Antigens and antibodies characteristic of systemic lupus erythematosus. Bull Rheum Dis 1974: 24: 756–60
   Google Scholar
• Chubick A, Sontheimer RD, Gilliam JM, et al. An appraisal of tests for native DNA antibodies in connective tissue disease. Ann Intern Med 1978: 89: 186–92
   PubMed Web of Science ®Google Scholar
• Reichlin M, Mattioli M. Correlation of a precipitin reaction to an RNAprotein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus. N Engl J Med 1972: 286: 908–11
   PubMed Web of Science ®Google Scholar
• Alspaugh M, Maddison P. Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and Sjögren's syndrome? an Inter-laboratory collaboration. Arthritis Rheum 1979: 22: 796–8
   PubMedGoogle Scholar
• Alspaugh MA, Talal N, Tan EM. Differentiation and characterization of auto-antibodies and their antigens in Sjögren's syndrome. Arthritis Rheum 1976: 19: 216–22
   PubMed Web of Science ®Google Scholar
• Alspaugh MA, Tan EM. Antibodies to cellular antigens in Sjögren's syndrome. J Clin Invest 1975: 55: 1067–73
   PubMed Web of Science ®Google Scholar
• Nakamura RM, Tan EM. Recent progress in the study of autoantibodies to nuclear antigens. Hum Pathol 1978: 9: 85–91.
   PubMed Web of Science ®Google Scholar
• Mackay IR. Chronic active hepatitis, cirrhosis and other diseases of the liver. In? Samter M. ed. Immunological diseases. 3rd ed. Boston? Little Brown. 1978
   Google Scholar
• Klatskin G, Kantor FS. Mitochondrial antibody in primary biliary cirrhosis and other diseases. Ann Intern Med 1972: 77: 533–41
   PubMed Web of Science ®Google Scholar
• Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 1973: 289: 674–8
   PubMed Web of Science ®Google Scholar
• Lidman K. Clinical diagnosis in patients with smooth muscle antibodies? a study of a one-year material. Acta Med Scand 1976: 200: 403–7
   PubMedGoogle Scholar
• Andersen P. Correlation of smooth-muscle and nuclear antibodies in normal subjects. Clin Exp Immunol 1977: 27: 74–7
   PubMed Web of Science ®Google Scholar
• Farrow LJ, Holborow EJ, Johnson GD, et al. Autoantibodies and the hepatitis-associated antigen in acute infective hepatitis. Br Med J 1970: 2: 693–5
   PubMed Web of Science ®Google Scholar
• Whittington S. Irwin J, Mackay IR, et al. Smooth muscle antibody in “autoimmune” hepatitis. Gastroenterology 1966: 51: 499–505
   PubMed Web of Science ®Google Scholar
• Samloff IM, Kleinman MS, Turner MD, et al. Blocking and binding antibodies to intrinsic factor and parietal cell antibody in pernicious anemia. Gastroenterology 1968: 55: 575–83
   PubMed Web of Science ®Google Scholar
• Taylor KB. Immune aspects of pernicious anaemia and atrophic gastritis. Clin Haematol 1976: 5: 497–519
   PubMedGoogle Scholar
• Jeffries GH. Pernicious anemia and atrophic gastritis. In: Samter. ed.49 pp 1296–1307
   Google Scholar
• Goldberg LS, Bluestone R, Stiehm ER, et al. Human autoimmunity with pernicious anemia as a model. Ann Intern Med 1974: 81: 322–80
   Google Scholar
• Irvine WJ, Davies SH, Teitelbaum S, et al. The clinical and pathological significance of gastric parletal cell antibody. Ann NY Acad Sci 1965: 124: 657–91
   PubMed Web of Science ®Google Scholar
• Ungar B, Stocks AE, Martin FI, et al. Intrinsic factor antibody, parietal cell antibody, and latent pernicious anemia in diabetes mellitus. Lancet 1968: 2: 415–7
   PubMed Web of Science ®Google Scholar
• Fisher JM, Taylor KB. A comparison of autoimmune phenomena in pernicious anemia and chronic atrophic gastritis. N Engl J Med 1965: 272: 499–503
   PubMed Web of Science ®Google Scholar
• Beall GN, Solomon DH. Hashimoto's disease and Graves” disease. In: Samter. ed.49 pp 1261–77
   Google Scholar
• Rose NR, Wtebsky E. Thyroid autoantibodies in thyroid disease. In: Levine K. ed. Advances in metabolic disorders. Vol 3. New York: Academic Press. 1968
   Google Scholar
• Rose NR. Endocrine diseases. In: Fudenberg et al. eds,42 pp 644–57
   Google Scholar
• Kahn CR, Megyesi K, Bar RS, et al. Receptors for peptide hormones: new insights into the pathophysiology of disease states in man. Ann Intern Med 1977: 86: 205–19
   PubMed Web of Science ®Google Scholar